Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT07632898 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07632898
- Sponsor
- Inhibikase Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-23
- Primary completion
- 2030-06-30
- Enrollment
- 484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.